Imjudo 00310-4505-25

Generic: Tremelimumab

Package NDC

00310-4505-25

Manufacturer: Astrazeneca Pharmaceuticals Lp
Dosage Form: Injection, Solution
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: October 21, 2022
Listing Expires: December 31, 2026
Application: BLA761289

Need to source Imjudo? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Tremelimumab	25 mg/1.25mL

Drug Class

CTLA-4-directed Blocking Antibody [EPC]CTLA-4-directed Antibody Interactions [MoA]CTLA-4-directed Blocking Antibody [EPC]

Selected Package

00310-4505-25Selected

1 VIAL in 1 CARTON (0310-4505-25) / 1.25 mL in 1 VIAL